Department of Health – Abu Dhabi and biopharma firm MSD GCC announce collaboration

The Department of Health – Abu Dhabi (DoH) has signed a declaration of collaboration with global biopharmaceutical company, MSD GCC.

According to state news agency WAM, the agreement between the entities was signed at the BIO International Convention in San Diego, US.

Abdulla bin Mohammed Al Hamed, chairman of the DoH, led the delegation, which is visiting the US this month to expand and explore prospects of joint collaboration in the healthcare sector.

Department of Health – Abu Dhabi, MSD GCC sign declaration of collaboration#WamNews https://t.co/8QRNp2vJot pic.twitter.com/N14kORZ1Ov

— WAM English (@WAMNEWS_ENG) June 15, 2022

The first area for collaboration will look at scientific research and also identify ways to improve public health.

The second area will include continuing medical education programmes for healthcare professionals and promoting patient and public healthcare education through teaching programmes and awareness campaigns.

The third area for collaboration will focus on increasing the use of innovative technological and digital health solutions to provide the highest quality care outcome. Activities include exploring the use of digital technology, artificial intelligence and innovation for precision and personalised medicine to improve diagnosis and optimise the delivery of care.

Dr Asma Al Mannaei, executive director, Research Centre and Innovation, at DoH said, “Under the directives of our wise leadership, Abu Dhabi is leading the transformation of the regional healthcare ecosystem by leveraging sciences and technology, reinforcing its position as a global leader in life sciences and an incubator for healthcare innovation. Through partnerships such as this, we can ensure our future initiatives and ongoing efforts will strengthen and further empower the emirate’s healthcare offering and ultimately improve the well-being of all members in our society.”

Ashraf Mallak, MD for MSD in the GCC, said, “The DoH has established one of the most innovative and sustainable healthcare systems in the world. We are also delighted to have hosted the DoH at the MSD Research Laboratories in Boston, the first visit of a UAE delegation to our research facilities. The DoH continues to increase access to innovative medicines and vaccines and supports the improvement of the health and wellness of the UAE’s people.”